 |
|
Unreported Financial Disclosures
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: We wish to notify you and the JAMA readers of undisclosed potential conflicts of interest with respect to an article that we published in JAMA in 20061 and a letter to the editor we published in JAMA in 2007.2
From 2000 to 2007, the Cornell Research Foundation Inc (CRF), a subsidiary of Cornell University, filed patent applications that cover a variety of computer-aided diagnostic methods, including measurement of nodules. These applications are for general diagnostic use. We are listed as co-inventors, among others. Starting in 2001, the CRF licensed certain of these technologies to General Electric and has received royalties. The license agreement was between General Electric and Cornell, the institution listed on the title page. A portion of the royalties are distributed to both of us and to the other co-inventors pursuant to Cornell policy, which in turn is consistent with the Bayh-Dole Act. One patent . . . [Full Text of this Article]
Claudia I. Henschke, PhD, MD
chensch@med.cornell.edu
David F. Yankelevitz, MD
Department of Radiology
Weill Medical College of Cornell University
New York, New York
RELATED ARTICLE
Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
International Early Lung Cancer Action Program Investigators
JAMA. 2006;296(2):180-184.
ABSTRACT
| FULL TEXT
RELATED LETTER
Unreported Financial Disclosures—Reply
Catherine D. DeAngelis
JAMA. 2008;299(15):1771.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Erratum: Correction of Conflict of Interest Statement
Abraham
Am. J. Respir. Crit. Care Med. 2008;178:542-542.
FULL TEXT
|
